Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Stock Information for Vaxart Inc.
Loading
Please wait while we load your information from QuoteMedia.